Shikata, Eiji Tokushima University
Miyamoto, Takeshi Tokushima University
Yamaguchi, Tadashi Tokushima University
Yamaguchi, Izumi Tokushima University Tokushima University Educator and Researcher Directory KAKEN Search Researchers
Kagusa, Hiroshi Tokushima University Tokushima University Educator and Researcher Directory
Gotoh, Daiki Tokushima University
Shimada, Kenji Tokushima University Tokushima University Educator and Researcher Directory
Tada, Yoshiteru Tokushima University Tokushima University Educator and Researcher Directory KAKEN Search Researchers
Yagi, Kenji Tokushima University KAKEN Search Researchers
Kitazato, Keiko T. Tokushima University
Kanematsu, Yasuhisa Tokushima University Tokushima University Educator and Researcher Directory KAKEN Search Researchers
Takagi, Yasushi Tokushima University Tokushima University Educator and Researcher Directory
mineral corticoid receptor
Thesis or Dissertation
Background and purpose: An aneurysmal subarachnoid hemorrhage is a devastating event. To establish an effective therapeutic strategy, its pathogenesis must be clarified, particularly the pathophysiology of brain harboring intracranial aneurysms (IAs). To elucidate the pathology in brain harboring IAs, we examined the significance of the receptor for advanced glycation end-products (RAGE)/mineralocorticoid receptor (MR) pathway and Na+/K+-ATPase (ATP1α3).
Methods: Ten-week-old female rats were subjected to oophorectomy as well as hypertension and hemodynamic changes to induce IAs, and were fed a high-salt diet. Brain damage in these rats was assessed by inflammatory changes in comparison to sham-operated rats fed a standard diet.
Results: Six weeks after IA induction (n = 30), irregular morphological changes, i.e., an enlarged vessel diameter and vascular wall, were observed in all of the left posterior cerebral arteries (Lt PCAs) prone to rupture. Approximately 20% of rats had ruptured IAs within 6 weeks. In brain harboring unruptured IAs at the PCA, the mRNA levels of RAGE and MR were higher, and that of ATP1α3 was lower than those in the sham-operated rats (p < 0.05, each). Immunohistochemically, elevated expression of RAGE and MR, and decreased expression of ATP1α3 were observed in the brain parenchyma adjacent to the Lt PCA, resulting in increased Iba-1 and S100B expression that reflected the inflammatory changes. There was no difference between the unruptured and ruptured aneurysm rat groups. Treatment with the MR antagonist esaxerenone abrogated these changes, and led to cerebral and vascular normalization and prolonged subarachnoid hemorrhage-free survival (p < 0.05).
Conclusions: Regulation of the imbalance between the RAGE/MR pathway and ATP1α3 may help attenuate the damage in brain harboring IAs, and further studies are warranted to clarify the significance of the down-regulation of the MR/RAGE pathway and the up-regulation of ATP1α3 for attenuating the pathological changes in brain harboring IAs.
Journal of Neuroinflammation
This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
|DOI (Published Version)|
|URL ( Publisher's Version )|
k3666_abstract.pdf 137 KB
k3666_review.pdf 113 KB
k3666_fulltext.pdf 1.91 MB
|MEXT report number||
Doctor of Medical Science